| Title : LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease - Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| Author(s) : Ruff CT , Koren MJ , Grimsby J , Rosenbaum AI , Tu X , Karathanasis SK , Falloon J , Hsia J , Guan Y , Conway J , Tsai LF , Hummer BT , Hirshberg B , Kuder J , Murphy SA , George RT , Sabatine MS |
| Ref : Arterioscler Thromb Vasc Biol , :ATVBAHA120315757 , 2021 |
| Abstract : Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| ESTHER : Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| PubMedSearch : Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| PubMedID: 34706556 |
Ruff CT, Koren MJ, Grimsby J, Rosenbaum AI, Tu X, Karathanasis SK, Falloon J, Hsia J, Guan Y, Conway J, Tsai LF, Hummer BT, Hirshberg B, Kuder J, Murphy SA, George RT, Sabatine MS (2021)
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
Arterioscler Thromb Vasc Biol
:ATVBAHA120315757
Ruff CT, Koren MJ, Grimsby J, Rosenbaum AI, Tu X, Karathanasis SK, Falloon J, Hsia J, Guan Y, Conway J, Tsai LF, Hummer BT, Hirshberg B, Kuder J, Murphy SA, George RT, Sabatine MS (2021)
Arterioscler Thromb Vasc Biol
:ATVBAHA120315757